Cefdinir
- Product NDC
- 43063-959
- 11-digit product format
- 430630959
- Labeler code
- 43063
- Product ID
- 43063-959_415f33e2-3d2e-2637-e063-6294a90affb1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cefdinir
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA065434
- Marketing category
- ANDA
- Marketing start
- 2008-01-07
- Substance
- CEFDINIR
- Active strength
- 300 mg/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cefdinir
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CEFDINIR | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | CI0FAO63WC |
| Rxcui | 200346 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 43063-959-14 | Cefdinir | 14 in 1 BOTTLE, PLASTIC | CAPSULE | 14 | | 24 |
| 43063-959-20 | Cefdinir | 20 in 1 BOTTLE, PLASTIC | CAPSULE | 20 | | 24 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43063-959 | CEFDINIR CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 23 | Current NDC, Legacy NDC, 2 package rows | 20240710_e296387e-eb20-4451-a184-f91748a4e9c7.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43063-959-14 | 43063095914 | 14 CAPSULE in 1 BOTTLE, PLASTIC (43063-959-14) | 14 capsule | 2024-03-12 | | No | No | Current |
| 43063-959-20 | 43063095920 | 20 CAPSULE in 1 BOTTLE, PLASTIC (43063-959-20) | 20 capsule | 2019-04-01 | 0000-00-00 | No | No | Current |